The buying came from people like me who recognise the potential...

The buying came from people like me who recognise the potential of DEM given it has recently recorded its strongest cash receipts in any single quarter, it's on target to meet its revenue forecast for CY2018, it's well-funded to meet its near-term growth prospects, it is pursuing project leads in Germany, has identified China as a key target market, and it plans to expand further into south-east Asia above and beyond Singapore and Vietnam. Add all of this to the low number off shares on issue and a market cap of $20m AUD and there is substantial upside for sharp share price appreciation to any positive news that might be released to the market going forward. 

Management's bullish statements from recent announcements also provide encouragement for prospective investors to get their toes wet as far as making an investment in DEM is concerned.

“We are aggressively building our technical capabilities and will present further proprietary membrane technologies to the market in coming months. These give us a major strategic advantage in the water and wastewater treatment market, and are helping drive more deployments across multiple industry sectors. These will surely translate into new revenue- generating contracts once the technology benefits are fully recognised." 

“We are well placed to meet our previously stated revenue target for CY2018 of between $10m and $12m and we have a number of growth initiatives underway to further strengthen our revenue base. Bidding activity is very favourable in Australia and Asia."

“We see a strong pipeline of projects building for 2019 in Australia and Asia, largely driven by strong infrastructure spending and the recovery in the mining sector. This is reflected in growing bidding activity.”